Tags

Windward Bio

Harbour BioMed and Windward Bio dose first COPD patients in Phase 2 SIRIUS study

Harbour BioMed and Windward Bio dose first COPD patients in Phase 2 SIRIUS study

June 10, 2026 | 11:06
Harbour BioMed and its partner Windward Bio have dosed the first patients in the Phase 2 SIRIUS study of HBM9378, a fully human ultra long-acting anti-TSLP antibody targeting chronic obstructive pulmonary disease.

Latest News

Suanova and InfiX.ai partner to deploy integrated AI platforms for healthcare applications

Suanova and InfiX.ai partner to deploy integrated AI platforms for healthcare applications

KAST adopts Elliptic blockchain intelligence for global AML and sanctions compliance

KAST adopts Elliptic blockchain intelligence for global AML and sanctions compliance

Credit Bureau Singapore and Experian Malaysia sign MoU for cross-border credit reporting

Credit Bureau Singapore and Experian Malaysia sign MoU for cross-border credit reporting

DHL adds 160,000 sqm of Asia Pacific warehousing capacity for data center logistics

DHL adds 160,000 sqm of Asia Pacific warehousing capacity for data center logistics

Vietnam Investment Review under the Ministry of Finance

Editor-in-Chief: Pham Van Hoanh

Deputy Editors-in-Chief: Le Trong Minh, Ngo Chi Tung, Nguyen Van Hong

Managing Editor: Nguyen Chi Mai

Advertisement  | Contact us

Based on MasterCMS Ultimate Edition 2026 v2.9
Corporate CEO Talk Biz Link PR Newswire Media OutReach Newswire
Investing M&A Outbound Investment Investing in Haiphong
Your Consultant KPMG PwC Indochine Counsel Vilasia
Green Growth Energy Efficiency Rethinking Plastics BASF
Property Green Buildings Industrial Properties
Money Insurance Smart Payment Trends Stock Monitor
Infographics
Timeout Travel Hotels & Restaurants The Insider Entertainment Lifestyle
Sports
Photos
Society Swing for the Kids CSR
World News
virs-publications-vir
timeout-vn
ptbv2020